Skip to main content
Clinical Trials/TCTR20201108003
TCTR20201108003
Completed
Phase 3

The Effect of Antenatal Dexamethasone to Improve Respiratory Neonatal Outcomes in Late Preterm Birth :A Randomized Controlled Trial

none0 sites194 target enrollmentNovember 8, 2020

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
rate of respiratory distress syndrome
Sponsor
none
Enrollment
194
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 8, 2020
End Date
January 31, 2020
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • Criteria for inclusion in the study were women (a) had preterm labor defined as regular uterine contractions before 37 weeks accompanied by a change of cervical dilatation, effacement, or both, or initial presentation with regular contractions and cervical dilatation at least 2 cm (16\) or (b) had spontaneous rupture of membranes (preterm PROM), diagnosed by pooling of fluid at posterior fornix with speculum examination, positive cough test and positive alkaline pH test or (c) had fetal or maternal indications for delivery between 34 and 36\+6 weeks gestation, such as placenta previa or fetal growth restriction.

Exclusion Criteria

  • We excluded women with multiple gestations, those who had received a previous course of corticosteroids, infection or chorioamnionitis (fetal tachycardia\>160 bpm, maternal fever \> 37\.8 °C and foul smelling amniotic fluid) during labor, overt diabetes mellitus, gestational diabetes mellitus, cervical dilation more than 5 centimeters, thrombocytopenia, allergy to corticosteroids, preeclampsia severe feature and HELP syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials